Back to Invesco Ltd. Invesco Ltd.

RCUSRCUS
Showing 8 of 26 quarters

Position history for Invesco Ltd.Invesco Ltd.'s holdings in Arcus Biosciences Inc

Yes. Invesco holds 845,233 shares of RCUS (Arcus Biosciences), worth $26.1M, as of its Q2 2026 13F filing. It increased the position by 24,413 shares (+3.0%) from Q1 2026. Invesco has held RCUS since Q1 2020, across 26 quarterly 13F filings.

Current Value

$26.1M

Current Shares

845,233

Total Value Change

+$23.5M

Total Shares Change

+677,151

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
845,233
+3.0%
$26.1M0.0%$30.83
30
2026-Q1
Increased
820,820
+98.1%
$17.7M0.0%$22.43
45
2025-Q4
Increased
414,365
+41.7%
$9.9M0.0%$23.23
37
2025-Q3
Increased
292,404
+16.1%
$4M0.0%$13.32
31
2025-Q2
Decreased
251,851
-0.9%
$2.1M0.0%$7.95
0
2025-Q1
Increased
254,024
+24.5%
$2M0.0%$8.17
32
2024-Q4
Increased
203,987
+21.4%
$3M0.0%$14.91
32
2024-Q3
Decreased
168,082
-7.9%
$2.6M0.0%$15.41
0

Other major holders of RCUS: BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used